Comparison of RightSpot pH Indicator & RightLevel pH Detector With X-Ray Verification for FT or G-Tube Placement

January 20, 2017 updated by: Timothy Havens, MD, St. Louis University

Comparison of the RightSpot pH Indicator & RightLevel pH Detector With the Gold Standard of Radiographic Verification of Feeding Tube Placement & Gastrostomy Tube Replacement

Replacing a G tube and placing feeding tubes is standard in the Emergency Department (ED) and ICU, respectively. However placement requires a chest or abdominal x-ray to confirm correct position. The investigators are testing the accuracy of the FDA approved devices RightSpot pH Indicator & RightLevel pH Detector in determining correct position based upon pH which will then be correlated with the standard of care x-ray.

Study Overview

Status

Terminated

Conditions

Detailed Description

Feeding tube placement is a common procedure that occurs in most ICU healthcare settings. In addition, replacement of G-tubes is a common practice in most ED settings throughout the US. Various practices have been used to confirm its placement, including the usage of litmus paper (acid versus base only), pH level indicators (precise measurement), auscultation, bubbling method, aspirate appearance, chest radiography (CXR) and gastrografin .

Review of data in numerous studies has revealed that many of these techniques may not provide fully accurate results, possibly leading to the potential for patient injuries, and even fatal complications. Auscultation, bubbling method, and aspirate appearance have been demonstrated to provide findings that can be misinterpreted and cause false assurance of correct placement. Several deaths and serious injuries have been attributed to the use of litmus paper in verification of feeding tube placement and subsequent utilization of the tube as well as G-tube replacement. Consequently, litmus paper is no longer considered to be a safe and effective confirmatory test for feeding tube placement or G-tube replacement.

Currently, the gold standard for verification of feeding tube placement is CXR or abdominal x-ray and G-tube replacement in an acute care setting is abdominal x-ray with gastrografin. This method is time-consuming, costly, and results in an increase in patient exposure to radiation. In addition for a patient who resides outside of the hospital setting at the time of needed G-tube replacement there is additional costs of transport to and from the ED. An alternative to CXR is measurement of gastric content pH level. This is a confirmed and valid tool for nasogastric/orogastric (NG/OG) verification and a recognized replacement of the litmus paper test.A pH level of 4.5 or less has been validated to indicate presence of gastric contents. A drawback to the use of typical pH indicators alone is that they require fluid aspirate to be placed manually onto the indicator surface. This increases the risk of exposure to bodily fluids for medical personnel. Thus, the ideal device to determine accurate feeding tube placement and G-tube replacement is one that will precisely measure the acid (pH) level of aspirate and significantly reduce the risk of bodily fluid exposure.

The RightSpot pH Indicator & RightLevel pH Detector are devices which purport to meet both of these criteria. Both can provide an accurate pH level. The pH paper is encased in a protective exterior that can be attached directly to a syringe, thus, decreasing the likelihood of accidental exposure.

This study will evaluate the use of this novel device to accurately verify feeding tube placement in an ICU care setting and G-tube replacement (of foley catheter) by measuring the pH and comparing this with gastrografin radiographic confirmation.

The G-tube (or foley catheter) will be placed by the treating physician, resident, mid-level provider or nurse as per policy and standard of care in the ICU or Emergency Department. Prior to x-ray confirmation of placement with gastrografin, the RightBio Metrics device will be placed on the tube as per manufacturer's instructions and stomach contents aspirated. The reading of the pH indicator and time it took to measure the pH will be recorded. The device will then be removed. Tube placement verification by x-ray will be done as per hospital protocol. The time of radiology reading of the x-ray will be documented.

Procedures for feeding tube are similar, however two pH measurements will be obtained. The first measurement will be obtained with RightSpot pH Indicator at the time the tube is inserted into the stomach to measure gastric pH, and the second pH measurement will be obtained one hour later with RightLevel pH Detector to assess whether or not a pH change has occurred that suggests the tube has migrated into the small bowel. Radiographic confirmation will also be obtained at that time as it is the standard of care for feeding tube placements at SLU Hospital.

Relevant aspects of subject's prior history will be recorded on a standardized data collection form (DCF). These include:

  • Demographics
  • Surgical history - when the G-tube was placed
  • Current medications
  • Any previous gastric bypass surgery or other GI surgery
  • Use of acid-reducing medications in the past week (e.g. antacids, proton pump inhibitors, histamine antagonists)
  • Relevant medical history (e.g. gastric ulcer, achlorhydria)
  • Cost related information such as ambulance cost to and from ED, cost of x-ray for G-tube (or foley) replacement, cost of radiographic interpretation

As this is a minimal risk device and the main endpoint is whether or not the device could determine placement of a feeding tube or G-tube, patients will not be followed beyond 24 hours.

Study Type

Observational

Enrollment (Actual)

11

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Missouri
      • St. Louis, Missouri, United States, 63110
        • Saint Louis University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Subjects will be recruited from the patients presenting to the Emergency Department for replacement of G-Tube or patients residing in the ICU that require placement of feeding tubes for enteral nutrition.

Description

Inclusion Criteria:

  • Age older than 18
  • Requirement for placement of a feeding tube or a G-tube replacement
  • Patient or proxy able to provide informed consent
  • English proficiency of person providing informed consent

Exclusion Criteria:

  • Patients that are younger than the age of 18
  • Inability to obtain consent
  • Grossly bloody aspirate
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pH measurement of gastric or duodenal secretions
Time Frame: Within 24 hours of tube insertion prior to the initiation of tube feeding
The pH measurement obtained will be used to determine correct placement of the gastric or feeding tube as compared to the gold standard method of X-ray following gastrograffin administration
Within 24 hours of tube insertion prior to the initiation of tube feeding

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Costs associated with G-tube reinsertion in the Emergency Department
Time Frame: Within 2 weeks of Discharge from the Emergency Department
A collection of all costs related to the Emergency Department visit related to the replacement of the G-tube
Within 2 weeks of Discharge from the Emergency Department

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Timothy Havens, MD, St. Louis University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 14, 2013

Primary Completion (Actual)

May 25, 2016

Study Completion (Actual)

May 25, 2016

Study Registration Dates

First Submitted

February 6, 2013

First Submitted That Met QC Criteria

April 1, 2013

First Posted (Estimate)

April 5, 2013

Study Record Updates

Last Update Posted (Estimate)

January 24, 2017

Last Update Submitted That Met QC Criteria

January 20, 2017

Last Verified

January 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • EZNG-SLU-450126, 22201

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gastrostomy

3
Subscribe